Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,815 across all filing types
Latest filing 2026-04-17 Foreign Filer Report
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
6-K - GENMAB A/S (0001434265) (Filer)
Foreign Filer Report
2026-04-17 English
6-K - GENMAB A/S (0001434265) (Filer)
Foreign Filer Report
2026-04-17 English
Genmab A/S Share Capital Reduction
Share Issue/Capital Change Classification · 1% confidence The document is a company announcement regarding the reduction of Genmab A/S’s share capital by cancelling shares, which is a change to the company’s capital structure. This fits the definition of “Share Issue/Capital Change” (Code: SHA) as it announces a capital change rather than reporting financial results or soliciting votes.
2026-04-17 English
Genmab A/S Share Capital Reduction
Share Issue/Capital Change Classification · 1% confidence The document is a company announcement detailing the reduction of Genmab A/S’s share capital (cancellation of shares and updated nominal share value). This is not a full report or financial results release but specifically an announcement of a capital change. It therefore fits the “Share Issue/Capital Change” category (SHA).
2026-04-17 English
6-K - GENMAB A/S (0001434265) (Filer)
Foreign Filer Report
2026-04-14 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 1% confidence The document is a notification of a change in a shareholder’s voting rights and share capital percentage, including threshold crossing details under the Capital Markets Act. It follows the standard form for major holdings disclosures (sections 7.1–7.3) and reports a change in percentage around a 5% threshold. This aligns exactly with a Major Shareholding Notification (MRQ).
2026-04-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.